Get started
ABBVIE INCABBVIE INCABBVIE INC

ABBVIE INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

ABBV trade ideas

ABBV - Potential Reversal coming 2019ABBV has been losing some value in their stock since January 2018.. Some trends we can see on the chart, are a couple fibonacci patterns, farthest on left is since the stock started, and closer on the right side is the latest dip on. The retrace has hit the long term 50% Fibonacci level and bounced off. Volume has been low, however. We draw trend lines and see a falling wedge pattern developing. This will usually call for a reversal, and we can start to use a couple other indicators as well. We can use Fibonacci retrace levels to assume when downward trend may hit major resistance. We can draw in our Moving Averages for future glimpses, and also take a look at RSI for selling volume, as the stock price falls. This is one I will be keeping my eye on, as we beak into 2019. I believe ABBV has good earnings potential, has a good dividend, and overall is a strong company. Being a Daily chart, we will be looking further down the road for this to play out. Smaller patterns will develop and play out before this may happen. Look for breakout of current trends to make any moves. I marked this chart as SHORT (short term only). I find it confusing when making a LONG call on longer term charts, while knowing the stock price is still expected to dip short term.
NYSE:ABBVShort
by Shwayze
ABBVIE - Technical AnalysisDear Traders, ABBVIE looks to be on the edge for a breakout, the MACD shows a Bullish Hidden Divergence which backs-up my LONG position. Any thoughts ? About Abbvie: AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.
NYSE:ABBVLong
by Raw_Blitz